Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

This trial is testing a new oral medication called HDM1002 for adults with Type 2 diabetes who are managing their blood sugar with diet and exercise alone (no diabetes drugs yet), to see if it safely lowers blood sugar levels. **You may be eligible if...** - You are between 18 and 75 years old with a confirmed Type 2 diabetes diagnosis of at least 10 weeks - You have been managing your diabetes with diet and exercise only (no blood sugar-lowering medication) for at least 10 weeks before signing consent - Your HbA1c (a 3-month blood sugar average) is between 7.5% and 10.5% - Your BMI is between 22.5 and 40.0 kg/m² - You agree to use highly effective contraception if applicable **You may NOT be eligible if...** - You are taking any blood sugar-lowering (hypoglycemic) medications - Your HbA1c is outside the 7.5–10.5% range - Your BMI is outside 22.5–40.0 kg/m² - You have been diagnosed with Type 2 diabetes for less than 10 weeks Talk to your doctor to see if this trial is right for you.